Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease
Autor: | M. Martin-Facklam, Aaron Ellenbogen, J. Soto, S.G. Griffith, S. Ostrowitzki, S.H. Issacson, I. Goodman, D.K. Ness, F.G. Boess, M. Koller, Joseph F. Quinn, M. Grundman, Beth Safirstein, G.G. Kinney, D.B. Schenk, Joseph Jankovic, Danna Jennings, O. Omidvar |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Alpha-synuclein Parkinson's disease medicine.drug_class business.industry medicine.disease Monoclonal antibody 03 medical and health sciences chemistry.chemical_compound 030104 developmental biology 0302 clinical medicine Neurology chemistry medicine Cancer research In patient Neurology (clinical) Geriatrics and Gerontology business 030217 neurology & neurosurgery |
Zdroj: | Parkinsonism & Related Disorders. 46:e25 |
ISSN: | 1353-8020 |
DOI: | 10.1016/j.parkreldis.2017.11.083 |
Databáze: | OpenAIRE |
Externí odkaz: |